BREAKING - Pfizer (PFE) SETTLES Tafamidis suit with two of three defendants

Written By yadhziwikwknxz

BREAKING - Pfizer (PFE) SETTLES Tafamidis suit with two of three defendants. Key question for analysts - how long will Pfizer’s patent protection last under the settlement? Based on available research, generics could be out of the market until 2033-2035. PFE BBIO ALNY

yadhziwikwknxz
Previous

Big Pharma names sit on UK panel shaping fallout from US-UK drugs trade pact
Next

Eli Lilly strikes $6.3bn deal for Centessa to bolster neuroscience pipeline